Roderick Wong
@Rtw Investments, Lp
Latest period2024 - Q3ReportedManaged Assets$6.911BTotal holdings68
Assets growth rate7%Assets growth rate (2-Q avg)1.18%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Rtw Investments, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 68 positions.
Assets under management
The assets under management (AUM) of Rtw Investments, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 6.911B in assets, with a quarterly growth rate of 7% and a 2-quarter average growth rate of 1.18%. The portfolio is managed by Roderick Wong, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
STOKStoke Therapeutics Inc
| 0.83% | $57.177M 4.652M shares@ $12.3 avg price | Increased 10.12% |
ETNB89bio Inc
| 0.8% | $54.601M 7.379M shares@ $7.4 avg price | |
CGONCg Oncology Inc
| 0.74% | $50.712M 1.344M shares@ $37.73 avg price | |
GKOSGlaukos Corp
| 0.73% | $50.326M 386,291 shares@ $130.28 avg price | |
URGNUrogen Pharma Ltd
| 0.7% | $48.099M 3.787M shares@ $12.71 avg price | Increased 6.47% |
NGNENeurogene Inc
| 0.69% | $47.635M 1.135M shares@ $41.97 avg price | Increased 6.05% |
ORKAOruka Therapeutics Inc
| 0.66% | $45.359M 1.851M shares@ $24.51 avg price | New Position |
OBIOOrchestra Biomed Hldgs Inc
| 0.62% | $42.18M 8.206M shares@ $5.14 avg price | Increased 46.01% |
SAGESage Therapeutics Inc
| 0.59% | $40.372M 5.592M shares@ $7.22 avg price | Increased 2.03% |
TSHATaysha Gene Therapies Inc
| 0.44% | $30.042M 14.946M shares@ $2.01 avg price | Decreased -20.49% |